These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17039083)

  • 1. Early onset methotrexate-induced pancytopenia and response to G-CSF: a report of two cases.
    Yoon KH; Ng SC
    J Clin Rheumatol; 2001 Feb; 7(1):17-20. PubMed ID: 17039083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should we manage low-dose methotrexate-induced pancytopenia in patients with rheumatoid arthritis?
    Cansu DÜ; Teke HÜ; Bodakçi E; Korkmaz C
    Clin Rheumatol; 2018 Dec; 37(12):3419-3425. PubMed ID: 30056523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of pancytopenia secondary to low-dose pulse methotrexate therapy in a patient with rheumatoid arthritis and renal insufficiency.
    Park GT; Jeon DW; Roh KH; Mun HS; Lee CH; Park CH; Kang KW; Kim SM; Kang JM; Park HC
    Korean J Intern Med; 1999 Jan; 14(1):85-7. PubMed ID: 10063319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe pancytopenia associated with low-dose methotrexate therapy for rheumatoid arthritis.
    Calvo-Romero JM
    Ann Pharmacother; 2001 Dec; 35(12):1575-7. PubMed ID: 11793624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis.
    Gutierrez-Ureña S; Molina JF; García CO; Cuéllar ML; Espinoza LR
    Arthritis Rheum; 1996 Feb; 39(2):272-6. PubMed ID: 8849378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Toxicity of low-dose methotrexate in rheumatoid arthritis--clinical characteristics in patients with MTX-induced pancytopenia and interstitial pneumonitis].
    Ohosone Y; Okano Y; Kameda H; Hama N; Matsumura M; Nojima T; Nakamura K; Kuwana M; Ogasawara T; Hirakata M; Yoshida T; Mimori T; Akizuki M; Ikeda Y
    Ryumachi; 1997 Feb; 37(1):16-23. PubMed ID: 9128419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
    Hocaoglu N; Atilla R; Onen F; Tuncok Y
    Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Methotrexate Toxicity Presenting as Pancytopenia.
    Dhillon GS; Chauhan S; Jalal Y; Ghobrial Y; Ahmed B
    Cureus; 2022 Dec; 14(12):e32494. PubMed ID: 36654616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years.
    Lim AY; Gaffney K; Scott DG
    Rheumatology (Oxford); 2005 Aug; 44(8):1051-5. PubMed ID: 15901903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancytopenia related eosinophilia in rheumatoid arthritis: a specific methotrexate phenomenon?
    Bruyn GA; Velthuysen E; Joosten P; Houtman PM
    J Rheumatol; 1995 Jul; 22(7):1373-6. PubMed ID: 7562775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methotrexate-induced pancytopenia: a case series of 46 patients.
    Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
    Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Myelosuppression Related to Low-Dose Methotrexate Therapy for Inflammatory Rheumatic Diseases.
    Mori S; Hidaka M; Kawakita T; Hidaka T; Tsuda H; Yoshitama T; Migita K; Ueki Y
    PLoS One; 2016; 11(4):e0154744. PubMed ID: 27128679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis--case report and review of literature].
    Kitsuwa S; Matsunaga K; Kawai M; Tsuzi T; Kato K; Tani K; Okubo T
    Ryumachi; 1996 Jun; 36(3):551-8. PubMed ID: 8779792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
    Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
    Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotton wool spots as an indicator of methotrexate-induced blood dyscrasia.
    Klemencic S
    Optometry; 2010 Apr; 81(4):177-80. PubMed ID: 20346888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthritis.
    MacKinnon SK; Starkebaum G; Willkens RF
    Semin Arthritis Rheum; 1985 Nov; 15(2):119-26. PubMed ID: 3877983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature.
    Yang CP; Kuo MC; Guh JY; Chen HC
    Ren Fail; 2006; 28(1):95-7. PubMed ID: 16526326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
    Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
    J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fatal pancytopenia and methotrexate-trimethoprim-sulfamethoxazole interaction].
    Bartha P; Bron R; Levy Y
    Harefuah; 2004 Jun; 143(6):398-400, 464. PubMed ID: 15524092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.